Found: 4
Select item for more details and to access through your institution.
The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 609, doi. 10.1093/oncolo/oyae107
- By:
- Publication type:
- Article
Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID‐19.
- Published in:
- Oncologist, 2021, v. 26, n. 8, p. 685, doi. 10.1002/onco.13794
- By:
- Publication type:
- Article
Time to SARS‐CoV‐2 clearance among patients with cancer and COVID‐19.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 5, p. 1545, doi. 10.1002/cam4.3708
- By:
- Publication type:
- Article
A Real-World Study of Patient Characteristics and Clinical Outcomes in EGFR Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical Practice.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1079, doi. 10.3390/cancers16061079
- By:
- Publication type:
- Article